What is the current state of Launch and Lifecycle work and how did it evolve?
The Effective Statistician - in association with PSI
00:00
Dosing and Dose Response in Drug Development
It is really essential when you are thinking of launching a drug, to remember that you're going to have to launch a drug under less restrictive conditions than you did in your pivital settings. So you need to understand all the constraints and limitations and potential pitfalls in that circumstance so that you can get the best outcome for patients. Ye, another example about dosing is is in e d actually. And there was e an observational study that looked into this. Interestingly, seloados was more effective than the iados. But of course, the hiados had more older patients had more commo. Both patients had more heavy weighed patients had lots of other kind of prognostic factors, a bad
Transcript
Play full episode
